The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach
Abstract
Aims: Whether immunohistochemical markers increase accuracy in predicting prognosis for gastrointestinal stromal tumours (GISTs) remains uncertain. However, past studies have used only small, heterogeneous patient groups. Our aim was to test previously studied and more novel morphological features as well as four immunohistochemical markers as prognostic indicators amongst a large cohort of surgically resected, gastric GISTs. Methods and results: Tissues from 127 gastric mesenchymal tumours were collected retrospectively and subjected to repeat histological assessment and immunophenotyping. Further immunohistochemistry was performed for Ki67, p53, Bcl‐2 and cyclin D1. Complete follow‐up data were collected for 108 patients with immunophenotyped diagnoses of GIST (i.e. c‐kit+ tumours). At the census point, 52 patients were alive, 24 had died from their GISTs and the remainder of other causes. Univariate analysis showed the following predicted for shorter disease‐specific survival: size ≥50 mm; necrosis, no intratumoral lymphocytes; mitotic count ≥5/50 high power fields; Ki67 labelling index ≥5%; p53 immunopositivity. Of these variables, multivariate analyses showed only mitotic count and, to a lesser extent, Ki67 labelling to be independent prognostic indicators. Conclusions: Mitotic count remains the best predictor of outcome following surgical resection of gastric GISTs. Ki67 immunohistochemistry does not provide better prognostication and p53, Bcl‐2 and cyclin D1 immunohistochemistry provide no additional prognostication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Cited by
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
Miettinen, M., & Lasota, J. (2006) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2006.09.001 · Cited by 2,052
Miettinen, M., Sobin, L. H., & Lasota, J. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146010.92933.de · Cited by 1,249
Gold, J. S., Gönen, M., Gutiérrez, A., Broto, J. M., García-del-Muro, X., Smyrk, T. C., Maki, R. G., Singer, S., Brennan, M. F., Antonescu, C. R., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70242-6 · Cited by 507
DeMatteo, R. P., Gold, J. S., Saran, L., Gönen, M., Liau, K. H., Maki, R. G., Singer, S., Besmer, P., Brennan, M. F., & Antonescu, C. R. (2008) · Cancer · doi:10.1002/cncr.23199 · Cited by 503
Interstitial cells of Cajal in health and disease
Farrugia, G. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01109.x · Cited by 383
Metadata
- Authors
- Wong, N. A. C. S., Young, R., Malcomson, R. D. G., Nayar, A. G., Jamieson, L. A., Save, V. E., Carey, F. A., Brewster, D. H., Han, C., & Al‐Nafussi, A.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2003-07-24
- Volume
- 43
- Issue
- 2
- Pages
- 118-126
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2081921707
- Cited by
- 164
- References
- 1
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. https://app.cochat.ai/papers/10.1046/j.1365-2559.2003.01665.x
- The paper
- Wong, N. A. C. S., Young, R., Malcomson, R. D. G., Nayar, A. G., Jamieson, L. A., Save, V. E., Carey, F. A., Brewster, D. H., Han, C., & Al‐Nafussi, A. (2003). Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology. https://doi.org/10.1046/j.1365-2559.2003.01665.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.